Fitbit announced the launch of large scale study into atrial fibrillation research and irregular heart rate detection. This heart study aims to attract thousands of users to enroll in this program to tracking and detecting heart rhythms on Fitbit watches. After the successful completion of clinical trials for the new ECG feature, the company will be looking forward to the approval of the FDA. Fitbit’s heart study intends to validate its new ECG feature for spot detection of AFib through its wearables.
To enroll in the study all the users should be older than 22 years, also the devices compatible with the study are Fitbit Charge 3, Charge 4, Versa, Versa 2, Versa Lite, Ionic, and Inspire HR. To collect information Fitbit device uses photoplethysmography (PPG) technology and measure the rate of blood from the user’s wrist. Fitbit’s new algorithm will help to analyze the user’s data and detect irregular heart rates. If participants report irregular heart rhythms, they will receive notification and get a virtual appointment with doctors for further analysis. Participants could also get ECG in their emails to confirm results.
Fitbit heart study indicates its approach towards heart health and efforts to conduct a mass study for advanced research. Apple Watch Series 5 and Galaxy Watch Active 2, Oppo Watch also offers the ECG feature to monitor heart health. However, Fitbit Mass study indicates that the ECG feature is on the way for the company’s wearables. ECG feature will perform as a key sensor that continuously monitors users’ heart rate and detect AFib and arrhythmia. It saves lives by warning users in case of any irregularity exists.
Longer battery life allows Fitbit watches for 24/7 heart rate tracking which means users can track their heart rate even during sleep. This gives the company an advantage over its many rivals like Apple and Samsung. AFib can lead to serious diseases like heart failure and stroke, timely detection of such irregularities may save users life. Advancement in R&D may lead to the introduction of new technology like Apple’s upcoming Pulse Oximeter which measures the saturation level of oxygen in the blood.